Dubreuil-Lemaire, M L <br/><br/>
Lenograstim for the treatment of neutropenia in patients receiving ganciclovir for cytomegalovirus infection: a randomised, placebo-controlled trial in AIDS patients.  [electronic resource] 

 -  European journal of haematology  Nov 2000 
 - 337-43 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0902-4441 
<br/><br/><label>Standard No.: </label>10.1034/j.1600-0609.2000.065005337.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS-Related Opportunistic Infections--complications<br/>Adjuvants, Immunologic--administration & dosage<br/>Adult<br/>Aged<br/>Antiviral Agents--administration & dosage<br/>Blood Cell Count<br/>Cytomegalovirus Infections--complications<br/>Dose-Response Relationship, Drug<br/>Drug Evaluation<br/>Female<br/>Ganciclovir--administration & dosage<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Hospitalization<br/>Humans<br/>Infections--etiology<br/>Lenograstim<br/>Male<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Neutrophils--cytology<br/>Recombinant Proteins--administration & dosage<br/>Time Factors